SHZNY Financial Statements & Analysis
Complete financial statements for SHZNY including income statement, balance sheet, and cash flow statement. Analyze SHZNY's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
-2.8% ↓
Net Income
-2.4% ↓
Gross Margin
-7.7% ↓
Operating Margin
13.3% ↑
Balance Sheet
Current Ratio
39.0% ↑
Debt to Equity
29.7% ↓
Asset Turnover
-8.1% ↓
Cash Flow
Operating Cash Flow
39.7% ↑
Net Cash Flow
231.3% ↑
Free Cash Flow
20.8% ↑
Cash Flow to Debt
2.4% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 9.25B | 8.99B | 2.8% | |
| Gross Profit | 2.92B | 2.62B | 10.2% | |
| Operating Income | 1.80B | 1.98B | 10.2% | |
| Net Income | 1.15B | 1.12B | 2.4% | |
| EPS | 22.00 | 22.00 | 0.0% | |
| EBITDA | 4.05B | 4.38B | 8.3% | |
| Gross Margin | 31.60% | 29.18% | 7.7% | |
| Operating Margin | 19.42% | 22.00% | 13.3% | |
| Net Income Margin | 12.38% | 12.44% | 0.4% | |
| R&D Expenses | 32.93M | 41.54M | 26.1% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 8.99B | 9.25B | 9.30B | — | — |
| Gross Profit | 2.62B | 2.92B | 3.35B | — | — |
| Operating Income | 1.98B | 1.80B | 3.01B | — | — |
| Net Income | 1.12B | 1.15B | 2.33B | — | — |
| EPS | 22.00 | 22.00 | 53.50 | — | — |
| EBITDA | 4.38B | 4.05B | 5.04B | — | — |
| Gross Margin | 29.18% | 31.60% | 36.00% | — | — |
| Operating Margin | 22.00% | 19.42% | 32.42% | — | — |
| Net Income Margin | 12.44% | 12.38% | 25.04% | — | — |
| R&D Expenses | 41.54M | 32.93M | 33.48M | — | — |
Financial Metrics
Want to dive deeper into SHZNY's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics